Results 141 to 150 of about 1,203 (200)

Inhibition mechanism of the fungal β-1,3-glucan synthases by triterpenoid antifungal drugs. [PDF]

Nat Commun
You ZL, Sun L, Wang LX, Ni YR, Lyu RQ, Chen DD, Yun CH, Song T, Song Y, Bai L.   +9 more
europepmc   +1 more source

A cost-effectiveness analysis of the use of oral ibrexafungerp versus fluconazole for acute vulvovaginal candidiasis in the UK NHS primary care service [PDF]

Viraj Shah, Anjali Cyril, Peter Koleoso, Arunesh Ragutharan, Faiz Mohammed, Pathusha Pushpakanthan   +5 more
openalex   +1 more source

Past, present and future of antifungals: Advancements in mechanisms of action and resistance. [PDF]

Curr Res Microb Sci
Santos ALS, Rodrigues CF, Roudbary M, Branquinha MH.   +3 more
europepmc   +1 more source

P-1096. Activity of Ibrexafungerp and Comparator Antifungals Tested against Candida and Aspergillus Isolates Collected from Invasive Infections in a Global Surveillance Program in 2023

Marisa Winkler, Paul R. Rhomberg, Abigail Klauer, Samuel Edeker, Sharon Min, Mariana Castanheira   +5 more
openalex   +1 more source

SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]

J Antimicrob Chemother
Spruijtenburg B, de Groot T, Meijer EFJ.
europepmc   +1 more source

A Novel 1,3-Beta- d -Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis [PDF]

, 2019
Emily L. Larkin, L. Long, N. Isham, Katyna Borroto–Esoda, Stephen Barat, D. Angulo, Steve Wring, Mahmoud A. Ghannoum   +7 more
openalex   +1 more source

Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]

Pharmaceuticals (Basel)
Squitieri D, Rizzo S, Torelli R, Mariotti M, Sanguinetti M, Cacaci M, Bugli F.   +6 more
europepmc   +1 more source

<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]

Antimicrob Agents Chemother
Garbe E, Ullah A, Aldejohann AM, Kurzai O, Janevska S, Walther G.   +5 more
europepmc   +1 more source

Faculty Opinions recommendation of The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2021
openaire   +2 more sources

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methods. [PDF]

JAC Antimicrob Resist
Ceballos-Garzon A, Holzapfel M, Welsch J, Mercer D.   +3 more
europepmc   +1 more source